Ashley Hall

Insider Reports History

Location
South San Francisco, CA
Signature
/s/ Jun Yoon, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Ashley Hall:

Company Role Class Num Shares Value Price $ Report Date Ownership
Structure Therapeutics Inc. Chief Development Officer Ordinary Shares 112,317 $869,704 $7.74 18 Sep 2025 Direct
Reneo Pharmaceuticals, Inc. Chief Development Officer Common Stock 39,600 $248,518 $6.28 28 Aug 2023 Direct
Structure Therapeutics Inc. Chief Development Officer Employee Stock Option (right to buy) 124,032 15 Mar 2025 Direct
Reneo Pharmaceuticals, Inc. Chief Development Officer Stock option (right to buy) 109,375 28 Aug 2023 Direct

Insider Reports Filed by Ashley Hall

Symbol Company Period Transactions Value $ Form Type Role Filing Time
GPCR Structure Therapeutics Inc. 18 Sep 2025 1 -$46,622 4 Chief Development Officer 22 Sep 2025, 21:25
GPCR Structure Therapeutics Inc. 15 Mar 2025 2 $0 4 Chief Development Officer 18 Mar 2025, 20:45
GPCR Structure Therapeutics Inc. 18 Sep 2024 2 $0 4 Chief Development Officer 20 Sep 2024, 17:47
GPCR Structure Therapeutics Inc. 18 Sep 2024 0 $0 3 Chief Development Officer 20 Sep 2024, 17:45
OKUR Reneo Pharmaceuticals, Inc. 28 Aug 2023 3 -$69,933 4 Chief Development Officer 29 Aug 2023, 18:04
OKUR Reneo Pharmaceuticals, Inc. 09 Dec 2022 1 $0 4 Chief Development Officer 13 Dec 2022, 17:11
OKUR Reneo Pharmaceuticals, Inc. 12 Nov 2021 2 $0 4 Chief Development Officer 15 Nov 2021, 18:49
OKUR Reneo Pharmaceuticals, Inc. 11 Oct 2020 0 $0 3 Chief Development Officer 14 Oct 2021, 16:39